tiprankstipranks
Advertisement
Advertisement

Craneware Completes $25m Share Buyback, Sets New Voting Rights

Story Highlights
  • Craneware has completed a $25m share buyback, repurchasing 1,276,957 shares now held in treasury.
  • The buyback tightens free float, supports employee incentives, and signals confidence in Craneware’s long-term value.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Craneware Completes $25m Share Buyback, Sets New Voting Rights

Claim 55% Off TipRanks

Craneware ( (GB:CRW) ) has issued an announcement.

Craneware has completed a $25m share buyback programme initiated in March 2026, repurchasing a total of 1,276,957 ordinary shares that will be held in treasury to cover existing employee share options and long-term incentive plan awards. The final tranche, executed on 12 May, saw 43,134 shares bought on the London Stock Exchange at a volume-weighted average price of 1,501.21p, leaving 34,237,148 shares in issue and establishing the new total voting rights for shareholders under UK disclosure rules.

By retiring the repurchased stock into treasury rather than cancelling it, Craneware tightens its free float while preserving flexibility to satisfy equity-based compensation without issuing new shares, a move that can help limit future dilution. The completed buyback underscores the company’s capital management discipline and may be interpreted by investors as a signal of confidence in its valuation and long-term prospects within the healthcare financial performance sector.

Spark’s Take on CRW Stock

According to Spark, TipRanks’ AI Analyst, CRW is a Neutral.

The score is driven primarily by solid financial performance (strong margins and a low-debt balance sheet), but it is meaningfully weighed down by weak technical momentum (price below key moving averages with negative MACD) and a relatively high P/E that limits valuation support despite the dividend yield.

To see Spark’s full report on CRW stock, click here.

More about Craneware

Craneware plc, listed on AIM as CRW.L, is a healthcare technology company specialising in financial and operational performance solutions for healthcare providers. Its Trisus cloud ecosystem integrates data, revenue and margin intelligence, and advanced analytics to help hospitals and health systems optimise financial sustainability and operational efficiency.

Average Trading Volume: 250,755

Technical Sentiment Signal: Sell

Current Market Cap: £527.4M

For detailed information about CRW stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1